Allergenicity assessment of novel foods - lessons from immune endotyping of food-allergic patients - Report - MDSpire

Allergenicity assessment of novel foods - lessons from immune endotyping of food-allergic patients

  • By

  • Isabela Assugeni

  • Melike Gezen

  • Gül Duman

  • Naphisabet Wanniang

  • Françoise Codreanu-Morel

  • Gabriele Gadermaier

  • Theresa-Maria Boehm

  • Annette Kuehn

  • June 10, 2026

  • 0 min

Share

Clinical Report: Evaluation of Allergenicity in Novel Foods

Overview

This report discusses the allergenic potential of novel foods (NF) and highlights the importance of immune endotyping in food allergy (FA) patients. It emphasizes the limitations of current safety assessment guidelines and the need for advanced immune profiling techniques.

Background

Food allergies affect a significant portion of the population, particularly children, and pose a public health challenge. As novel foods gain popularity, understanding their allergenic potential is crucial for consumer safety. Current guidelines for assessing allergenicity in NF are limited, particularly regarding de novo sensitization, necessitating improved methodologies for evaluation.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

  • Food allergy affects up to 10% of the global population, with increasing prevalence among children.
  • Current guidelines for novel food safety assessment focus on known allergens but lack direction for unknown allergenic potential.
  • Conventional IgE testing often fails to predict clinically relevant immune responses in humans.
  • Immune endotyping can differentiate between food allergy, asymptomatic IgE sensitization, and healthy states based on immune cell reactivity.
  • Recent reviews indicate that allergenicity risk is likely in 50% of approved novel foods.

Clinical Implications

Healthcare professionals should be aware of the limitations in current allergenicity assessments for novel foods. Advanced immune profiling techniques may provide better insights into the allergenic potential of these foods, aiding in patient management.

Conclusion

The evaluation of allergenicity in novel foods requires enhanced methodologies, particularly through immune endotyping, to ensure consumer safety and effective management of food allergies.

Related Resources & Content

  1. Conexiant, Major Food Allergy Risks Clarified, 2023 -- Major Food Allergy Risks Clarified
  2. Frontiers in Immunology, Immunogenetic HLA-DQ and IgG serological profiles in individuals with self-reported wheat/gluten sensitivity: a retrospective real-world evidence study, 2026 -- Immunogenetic HLA-DQ and IgG serological profiles in individuals with self-reported wheat/gluten sensitivity
  3. JAMA Pediatrics, Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and, 2023 -- Risk Factors for the Development of Food Allergy in Infants and Children
  4. Guidance on the scientific requirements for an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283, 2024 -- EFSA Journal
  5. Ad hoc Joint FAO/WHO Expert Consultation on Risk Assessment of Food Allergens, 2025 -- guidance for risk assessment
  6. Frontiers in Immunology — Editorial: Exploring immunological tolerance in allergy treatment through AIT
  7. Guidance on the scientific requirements for an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 - - 2024 - EFSA Journal - Wiley Online Library
  8. Ad hoc Joint FAO/WHO Expert Consultation on Risk Assessment of Food Allergens – guidance for risk assessment
  9. Food allergy endotypes revisited - ScienceDirect
  10. Basophil Activation Test (BAT) for Diagnosing LTP Food Allergy: Where Do We Stand Now? A Systematic Review - PMC
  11. Omalizumab treats multi-food allergy better than oral immunotherapy | National Institutes of Health (NIH)

Original Source(s)

Related Content